BioPharma Credit PLC
BOPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,080,567 | $1,099,905 | $1,305,235 | $1,329,966 |
| - Cash | $5,620 | $86,202 | $120,527 | $94,709 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,074,947 | $1,013,703 | $1,184,708 | $1,235,257 |
| Revenue | $124,457 | $159,682 | $213,771 | $126,394 |
| % Growth | -22.1% | -25.3% | 69.1% | – |
| Gross Profit | $124,457 | $110,487 | $184,245 | $87,969 |
| % Margin | 100% | 69.2% | 86.2% | 69.6% |
| EBITDA | $122,178 | $0 | $0 | $0 |
| % Margin | 98.2% | 0% | 0% | 0% |
| Net Income | $122,178 | $108,450 | $182,311 | $84,959 |
| % Margin | 98.2% | 67.9% | 85.3% | 67.2% |
| EPS Diluted | 0.1 | 0.083 | 0.13 | 0.062 |
| % Growth | 20.8% | -36.3% | 110.4% | – |
| Operating Cash Flow | $111,912 | $123,182 | $184,277 | $96,436 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $111,912 | $123,182 | $184,277 | $96,436 |